vs
金佰利（KMB）与福泰制药（VRTX）财务数据对比。点击上方公司名可切换其他公司
金佰利的季度营收约是福泰制药的1.3倍（$4.2B vs $3.2B），福泰制药净利率更高（37.3% vs 16.2%，领先21.1%），福泰制药同比增速更快（9.5% vs 2.7%），过去两年福泰制药的营收复合增速更高（8.9% vs -9.0%）
金佰利是源自美国的跨国消费品及个人护理集团，主打纸质类消费品，同时生产卫生用纸制品、外科及医疗器具。旗下拥有舒洁面巾纸、高洁丝女性护理产品、好奇纸尿裤及婴儿湿巾、Scott卫生纸等知名品牌，产品销往全球多个国家和地区。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业，是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外，公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
KMB vs VRTX — 直观对比
营收规模更大
KMB
是对方的1.3倍
$3.2B
营收增速更快
VRTX
高出6.9%
2.7%
净利率更高
VRTX
高出21.1%
16.2%
两年增速更快
VRTX
近两年复合增速
-9.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.2B | $3.2B |
| 净利润 | $675.0M | $1.2B |
| 毛利率 | 36.8% | 85.4% |
| 营业利润率 | 18.1% | 37.8% |
| 净利率 | 16.2% | 37.3% |
| 营收同比 | 2.7% | 9.5% |
| 净利润同比 | 17.8% | 30.5% |
| 每股收益（稀释后） | $2.00 | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMBVRTX
| Q1 26 | $4.2B | — | ||
| Q4 25 | $3.3B | $3.2B | ||
| Q3 25 | $4.2B | $3.1B | ||
| Q2 25 | $4.2B | $3.0B | ||
| Q1 25 | $4.8B | $2.8B | ||
| Q4 24 | $4.9B | $2.9B | ||
| Q3 24 | $5.0B | $2.8B | ||
| Q2 24 | $5.0B | $2.6B |
净利润KMBVRTX
| Q1 26 | $675.0M | — | ||
| Q4 25 | $499.0M | $1.2B | ||
| Q3 25 | $446.0M | $1.1B | ||
| Q2 25 | $509.0M | $1.0B | ||
| Q1 25 | $567.0M | $646.3M | ||
| Q4 24 | $447.0M | $913.0M | ||
| Q3 24 | $907.0M | $1.0B | ||
| Q2 24 | $544.0M | $-3.6B |
毛利率KMBVRTX
| Q1 26 | 36.8% | — | ||
| Q4 25 | 37.7% | 85.4% | ||
| Q3 25 | 36.0% | 86.5% | ||
| Q2 25 | 35.0% | 86.3% | ||
| Q1 25 | 35.8% | 86.9% | ||
| Q4 24 | 34.0% | 85.5% | ||
| Q3 24 | 36.0% | 85.8% | ||
| Q2 24 | 36.0% | 85.9% |
营业利润率KMBVRTX
| Q1 26 | 18.1% | — | ||
| Q4 25 | 11.2% | 37.8% | ||
| Q3 25 | 15.0% | 38.6% | ||
| Q2 25 | 14.2% | 38.8% | ||
| Q1 25 | 15.9% | 22.7% | ||
| Q4 24 | 11.1% | 35.2% | ||
| Q3 24 | 23.3% | 40.3% | ||
| Q2 24 | 13.0% | -132.9% |
净利率KMBVRTX
| Q1 26 | 16.2% | — | ||
| Q4 25 | 15.1% | 37.3% | ||
| Q3 25 | 10.7% | 35.2% | ||
| Q2 25 | 12.2% | 34.8% | ||
| Q1 25 | 11.7% | 23.3% | ||
| Q4 24 | 9.1% | 31.4% | ||
| Q3 24 | 18.3% | 37.7% | ||
| Q2 24 | 10.8% | -135.8% |
每股收益（稀释后）KMBVRTX
| Q1 26 | $2.00 | — | ||
| Q4 25 | $1.50 | $4.64 | ||
| Q3 25 | $1.34 | $4.20 | ||
| Q2 25 | $1.53 | $3.99 | ||
| Q1 25 | $1.70 | $2.49 | ||
| Q4 24 | $1.34 | $3.62 | ||
| Q3 24 | $2.69 | $4.01 | ||
| Q2 24 | $1.61 | $-13.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $542.0K | $6.6B |
| 总债务越低越好 | $6.5M | — |
| 股东权益账面价值 | $1.9M | $18.7B |
| 总资产 | $17.2M | $25.6B |
| 负债/权益比越低杠杆越低 | 3.38× | — |
8季度趋势，按日历期对齐
现金及短期投资KMBVRTX
| Q1 26 | $542.0K | — | ||
| Q4 25 | $688.0M | $6.6B | ||
| Q3 25 | $617.0M | $6.3B | ||
| Q2 25 | $634.0M | $6.4B | ||
| Q1 25 | $563.0M | $6.2B | ||
| Q4 24 | $1.0B | $6.1B | ||
| Q3 24 | $1.1B | $6.5B | ||
| Q2 24 | $1.2B | $5.8B |
总债务KMBVRTX
| Q1 26 | $6.5M | — | ||
| Q4 25 | $6.5B | — | ||
| Q3 25 | $6.5B | — | ||
| Q2 25 | $6.5B | — | ||
| Q1 25 | $6.5B | — | ||
| Q4 24 | $6.9B | — | ||
| Q3 24 | $6.9B | — | ||
| Q2 24 | $7.2B | — |
股东权益KMBVRTX
| Q1 26 | $1.9M | — | ||
| Q4 25 | $1.5B | $18.7B | ||
| Q3 25 | $1.3B | $17.3B | ||
| Q2 25 | $1.3B | $17.2B | ||
| Q1 25 | $1.1B | $16.5B | ||
| Q4 24 | $840.0M | $16.4B | ||
| Q3 24 | $1.3B | $15.6B | ||
| Q2 24 | $1.1B | $14.8B |
总资产KMBVRTX
| Q1 26 | $17.2M | — | ||
| Q4 25 | $17.1B | $25.6B | ||
| Q3 25 | $16.9B | $24.9B | ||
| Q2 25 | $16.8B | $24.0B | ||
| Q1 25 | $16.3B | $22.9B | ||
| Q4 24 | $16.5B | $22.5B | ||
| Q3 24 | $17.2B | $22.2B | ||
| Q2 24 | $17.3B | $20.1B |
负债/权益比KMBVRTX
| Q1 26 | 3.38× | — | ||
| Q4 25 | 4.31× | — | ||
| Q3 25 | 4.86× | — | ||
| Q2 25 | 5.09× | — | ||
| Q1 25 | 5.89× | — | ||
| Q4 24 | 8.18× | — | ||
| Q3 24 | 5.36× | — | ||
| Q2 24 | 6.30× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $498.0M |
| 自由现金流经营现金流 - 资本支出 | — | $348.6M |
| 自由现金流率自由现金流/营收 | — | 10.9% |
| 资本支出强度资本支出/营收 | — | 4.7% |
| 现金转化率经营现金流/净利润 | — | 0.42× |
| 过去12个月自由现金流最近4个季度 | — | $3.2B |
8季度趋势，按日历期对齐
经营现金流KMBVRTX
| Q1 26 | — | — | ||
| Q4 25 | $972.0M | $498.0M | ||
| Q3 25 | $708.0M | $1.2B | ||
| Q2 25 | $770.0M | $1.1B | ||
| Q1 25 | $327.0M | $818.9M | ||
| Q4 24 | $817.0M | $584.6M | ||
| Q3 24 | $958.0M | $1.4B | ||
| Q2 24 | $1.0B | $-3.8B |
自由现金流KMBVRTX
| Q1 26 | — | — | ||
| Q4 25 | $575.0M | $348.6M | ||
| Q3 25 | $368.0M | $1.1B | ||
| Q2 25 | $573.0M | $927.4M | ||
| Q1 25 | $123.0M | $778.2M | ||
| Q4 24 | $608.0M | $492.0M | ||
| Q3 24 | $798.0M | $1.3B | ||
| Q2 24 | $863.0M | $-3.8B |
自由现金流率KMBVRTX
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | 10.9% | ||
| Q3 25 | 8.9% | 37.0% | ||
| Q2 25 | 13.8% | 31.3% | ||
| Q1 25 | 2.5% | 28.1% | ||
| Q4 24 | 12.3% | 16.9% | ||
| Q3 24 | 16.1% | 47.0% | ||
| Q2 24 | 17.2% | -144.5% |
资本支出强度KMBVRTX
| Q1 26 | — | — | ||
| Q4 25 | 12.1% | 4.7% | ||
| Q3 25 | 8.2% | 3.3% | ||
| Q2 25 | 4.7% | 4.9% | ||
| Q1 25 | 4.2% | 1.5% | ||
| Q4 24 | 4.2% | 3.2% | ||
| Q3 24 | 3.2% | 2.4% | ||
| Q2 24 | 3.1% | 2.6% |
现金转化率KMBVRTX
| Q1 26 | — | — | ||
| Q4 25 | 1.95× | 0.42× | ||
| Q3 25 | 1.59× | 1.15× | ||
| Q2 25 | 1.51× | 1.04× | ||
| Q1 25 | 0.58× | 1.27× | ||
| Q4 24 | 1.83× | 0.64× | ||
| Q3 24 | 1.06× | 1.31× | ||
| Q2 24 | 1.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KMB
| NA | $2.7B | 64% |
| IPC | $1.5B | 36% |
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
